martindale.com Legal Library
|
Haynes and Boone, LLP Washington, VA Document Search Results (10) Sort by:  | Recent U.S. Court Decisions Regarding Section viii "Carve-Outs" Michael M. Shen, Stephanie Sivinski; Haynes and Boone, LLP;
Legal Alert/Article May 17, 2012, previously published on May 15, 2012 Three recent decisions bolster a generic manufacturer’s ability to challenge Orange Book listings and obtain ANDA approval through section viii “carve-outs.” In Caraco v. Novo Nordisk the U.S. Supreme Court unanimously held Caraco could use the Hatch-Waxman’s counterclaim...
|  | Breaking the Chains of Prometheus: Practical Claim Drafting Kristen Beery, Jeffrey A. Wolfson; Haynes and Boone, LLP;
Legal Alert/Article April 10, 2012, previously published on April 6, 2012 some of that fire in the guise of Mayo Collaborative Servs. v. Prometheus Labs., Inc., No. 10-1150 (U.S. Mar. 20, 2012), the Supreme Court’s latest decision addressing patent-eligible subject matter. But a practical analysis of Prometheus reveals strategies one can use in drafting patent...
|  | Biosimilars: Draft Guidance Documents Issued by FDA Kimberly Weinreich, Jeffrey A. Wolfson; Haynes and Boone, LLP;
Legal Alert/Article February 14, 2012, previously published on February 14, 2012 The new abbreviated regulatory approval pathway for “biosimilar” and “interchangeable” types of biologic drug products was implemented in the Biologics Price Competition and Innovation Act of 2009 (BPCI Act) as part of the Patient Protection and Affordable Care Act of 2010....
|  | Practice Tips Under the Patent Reform Rules Tom Chen, Dustin T. Johnson, Andrew Lowes, Jeffrey A. Wolfson; Haynes and Boone, LLP;
Legal Alert/Article September 21, 2011, previously published on September 16, 2011 The long anticipated America Invents Act (the “Act”) was signed into law today. However, given that certain provisions of the Act are now in effect while others do not come online until March 16, 2013, innovating companies and individuals should consider the impact and timing of those...
|  | Conformity is a Virtue: The U.S. Patent and Trademark Office Proposes Changes to the Duty of Disclosure to Match the Therasense Standard Randall C. Brown, Tom Chen, Brent A. Folsom, Jeffrey A. Wolfson; Haynes and Boone, LLP;
Legal Alert/Article July 28, 2011, previously published on July 26, 2011 The U.S. Patent and Trademark Office (“PTO”) has proposed changes to two rules that are designed to streamline the obligations of innovators and their patent practitioners to disclose information to the PTO in patent applications and reexamination proceedings.
|  | Patent Reform 2011: It Could Happen to You Randall C. Brown, Tom Chen, Gregory P. Webb, Jeffrey A. Wolfson; Haynes and Boone, LLP;
Legal Alert/Article July 1, 2011, previously published on June 28, 2011 n June 23, 2011, the U.S. House of Representatives passed House Bill H.R. 1249 (the “Leahy-Smith America Invents Act”) by a vote of 304-117. This follows on the Senate’s 95-5 passage of bill S. 23 (the “America Invents Act”) back on March 8, 2011. As President Obama...
|  | The Status Quo Wins: Clear and Convincing Proof is Still Required to Invalidate Patent Claims David H. Harper, Steven M. Levitan, Kyle Musgrove, Kenneth G. Parker, Phillip B. Philbin; Haynes and Boone, LLP;
Legal Alert/Article June 15, 2011, previously published on June 13, 2011 The Supreme Court ruled last week in Microsoft Corporation v. i4i Limited Partnership that “clear and convincing evidence” is still the standard of proof required to invalidate a patent. Section 282 of the Patent Act states that “a patent shall be presumed valid” and that...
|  | Proceed With Caution: Does that Employment Agreement Have a Proper IP Assignment? Evert Farah To Uy, Jeffrey A. Wolfson; Haynes and Boone, LLP;
Legal Alert/Article June 14, 2011, previously published on June 9, 2011 The Supreme Court ruled earlier this week that the Bayh-Dole Act does not automatically vest title to federally funded inventions in federal contractors in Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc., et al. The Bayh-Dole Act generally enables...
|  | SEC Implements Whistleblower Bounty Program and Protections: Implications for Companies Kit Addleman, Michael M. Boone, Ronald W. Breaux, Michael J. Halloran, Gregory R. Samuel, Janice V. Sharry; Haynes and Boone, LLP;
Legal Alert/Article June 7, 2011, previously published on June 7, 2011 The Securities and Exchange Commission adopted on May 25, 2011, final rules to implement the Section 21F of the Securities Exchange Act of 1934 entitled “Securities Whistleblower Incentives and Protection.” The new rules have significant implications for public companies and securities...
|  | But-For Materiality and Tightened Inequitable Conduct Standards: The Therasense v. Becton, Dickinson En Banc Federal Circuit Decision Kyle Musgrove; Haynes and Boone, LLP;
Legal Alert/Article June 2, 2011, previously published on May 31, 2011 On May 25, 2011, the en banc Federal Circuit announced its decision in Therasense, Inc. v. Becton, Dickinson & Company regarding the appropriate standards for succeeding with an inequitable conduct defense. The majority decision by Chief Judge Rader requires separate findings of materiality and...
|
|